Most Read News

Following an inspection carried out from Nov 14-22 2024, the facility was cited as being ‘VAI’ (Voluntary Action Indicated).

In Q3 FY25, BHEL reported a 170% YoY increase in net profit, reaching ₹124 crore, while revenue grew 32% YoY to ₹7,277 crore, reflecting strong financial performance.

Zydus Lifesciences announced it's Q3 FY25 and net profit grew by 30% YoY.

As part of the contract, debentures shall have a tenure of 3,651 days (approx. 10 years) and shall be listed on the Wholesale Debt Market

EBITDA was up 14.8% and stood at ₹635 crore compared to ₹553.2 crore, indicating improved operational performance.

Revenue fell by 2.6% year-on-year to ₹4,567.4 crore against ₹4,689.3 crore in Q3 FY24, indicating a marginal slowdown in business activity.

However, the company stated that its revenue from operations registered a growth of 66.90% to ₹534.70 Crore in Q3FY25.

Top gainers in Sensex include Nestle (1.11%), TCS (0.27%), HCL Tech (0.27%), ITC (0.23%).

The company reported an 11.6% YoY de-growth in the same to ₹170 crore versus ₹192.2 crore in Q3 FY24.

The deal is aimed at improving operational efficiency, expanding capabilities, and fuel innovation in the maritime sector.